Immunotherapy in Multiple Myeloma.

Cinnie Yentia Soekojo, Melissa Ooi, Sanjay de Mel, Wee Joo Chng

Cells 2020 Mar 03

filter terms:

all
biogroup
compound
phenotype
show more »
show less «

Multiple myeloma is a complex disease and immune dysfunction has been known to play an important role in the disease pathogenesis, progression, and drug resistance. Recent efforts in drug development have been focused on immunotherapies to modify the MM disease process. Here, we summarize the emerging immunotherapies in the MM treatment landscape.